Gallize Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 9 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.95 Cr
About Gallize Pharmaceuticals Llp
Gallize Pharmaceuticals Llp (GPL) is 9 Year, 28 Days old Limited Liability Partnership 04 January 2016. Its registered office is in Ahmedabad, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAF-4255
-
Incorporation Date
04 Jan 2016
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Ahmedabad
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Gallize Pharmaceuticals Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaumil Modi
|
Designated Partner | 04-Jan-2016 | Current |
|
Shrujalbahen Modi
|
Designated Partner | 04-Jan-2016 | Current |
Financial Performance of Gallize Pharmaceuticals Llp.
Enhance accessibility to Gallize Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gallize Pharmaceuticals Llp?
Unlock access to Gallize Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tripada Lifecare Private LimitedKaumil Modi and Shrujalbahen Modi are mutual person
-
Tripada Healthcare Private LimitedKaumil Modi is a mutual person
-
Smonkare Impex Private LimitedKaumil Modi is a mutual person
-
Thc Pharma Wellness Private LimitedKaumil Modi is a mutual person
-
Nature Marketing Private Limited
Kaumil Modi is a mutual person
Charges (Loans)
₹29.50 M
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 2.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2021 | Icici Bank Limited | ₹1.80 Cr | Open |
| 07 Jul 2016 | Icici Bank Limited | ₹1.15 Cr | Open |
How Many Employees Work at Gallize Pharmaceuticals Llp?
Unlock and access historical data on people associated with Gallize Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gallize Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gallize Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
